Antibodies is a relatively new journal with a major focus on quick dissemination of knowledge related to antibodies, especially how to quickly translate basic research results to therapeutic applications. Because it covers all areas related to antibodies unexpected connections between different areas could be made, leading to major discoveries and opening new fields of research and development. This is enhanced by the large readership of the many antibody-related areas of research. A specific priority area is human monoclonal antibodies for therapy of diseases and aging.
MabDesign is a French non-profit membership organization that aims to federate, mobilize and support the development of the industrial sector in the field of immunotherapy. MabDesign provides strategic leverage and development opportunities for its members, through the creation of a unique directory of stakeholders; by developing specialized training solutions, by providing business development and marketing support; as well as the organisation and support of scientific events, thus promoting networking and innovation.
FierceBiotech and its family of publications provide end-to-end coverage of biotech and medtech, from pre-clinical science through clinical testing and regulatory approval—and all the seed funding, venture capital, licensing deals, IPOs and M&A that happen along the way. We track tiny, virtual startups and the biggest of Big Pharma, highlighting the accomplishments and acknowledging the defeats that all of them experience on their way to market with a new therapy or device. The FierceBiotech team transcends the daily as well, with comprehensive coverage of key medical meetings plus special reports that highlight up-and-comers and shed new light on industry heavyweights.
Pharmaphorum media is the premier digital publisher of thought leadership relating to the pharmaceutical industry. The news, opinions and insights published every day help industry executives better understand the broader healthcare landscape within which they operate, including regular contributions from their peers, innovative service providers... Read More
The Antibody Society is a non-profit association representing individuals and organizations involved in antibody research and development. We engage in activities that broadly benefit our members, such as education and publishing, and encourage collaboration between companies, academia and government organizations.
Search the Antibody Resource database of 2 million antibody and Elisa products, from 170 suppliers covering 27000 proteins. With thousands of proteins and often hundreds of associated antibodies, the selection of a specific antibody can be both time-consuming and expensive. Antibody Resource is spearheading a unique initiative designed to compare antibodies from numerous suppliers using identical samples/tissues and an identical protocol. In doing so, we hope to enable scientists to form an unrivalled opinion of which is the most suitable antibody for their research.
Hanson Wade's goal is to accelerate progress within organizations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.